Skip to content

Effect on choroidal blood flow following VR blue light exposure on peripheral retina

Effect on choroidal blood flow following VR blue light exposure on peripheral retina

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086222
Enrollment
Unknown
Registered
2024-06-27
Start date
2024-06-27
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Blue light group:40 minutes a day of low doses of blue light exposure (60 melanopic lux, 6Hz-20Hz) with VR devices.
Blue light+defocus group:40 minutes a day of low doses of peripheral defocus signal and blue light exposure (60 melanopic lux, 6Hz-20Hz) with VR devices.

Sponsors

Eye and ENT Hospital of Fudan University (Shanghai, China)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 40 Years

Inclusion criteria

Inclusion criteria: Children, adolescents and adults between 8 and 40 years old with myopia progression (progression of children under 18 years old: no less than -0.75D per year, progression of adults over 18 years old: no less than -0.50D per year) were randomly selected.

Exclusion criteria

Exclusion criteria: 1. Not able to cooperate with relevant examinations. 2. Existence of organic eye disease which compromises best corrected visual acuity, and other ocular and systematic diseases that considered by the investigator to be inappropriate for participation in the study. 3. History of mental or CNS diseases. 4. Other conditions considered by the investigator to be inappropriate for participation in the study.

Design outcomes

Primary

MeasureTime frame
Axial length;corneal curvature;Uncorrected visual acuity;Refractive error;Bilateral visual function;

Secondary

MeasureTime frame
choroidal blood flow;choroidal thickness;

Countries

China

Contacts

Public ContactXingtao Zhou

Eye and ENT Hospital of Fudan University (Shanghai, China)

doctzhouxingtao@163.com+86 21 6437 7134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026